BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6346317)

  • 1. [Insulin, glucagon and C-peptide content in the blood of acromegaly patients].
    Molitvoslovova NN
    Probl Endokrinol (Mosk); 1983; 29(3):21-4. PubMed ID: 6346317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of parlodel on carbohydrate metabolism regulation in acromegaly].
    Molitvoslovova NN
    Sov Med; 1984; (1):24-9. PubMed ID: 6701649
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relationship between fasting glycemia, serum peptide C, insulin, growth hormone and plasma glucagon in acromegaly].
    Piniewska-Hułas D; Lewandowski Z; Kasperska-Dworak A; Bonicki W
    Pol Arch Med Wewn; 1996 Jun; 95(6):524-33. PubMed ID: 9005421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dynamics of the glucagon and C-peptide content in Itsenko-Cushing disease].
    Arapova SD; Zavadskiĭ PS; Marova EI
    Sov Med; 1980; (2):42-7. PubMed ID: 6987746
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glucagon, C-peptide and insulin content in the blood of healthy children].
    Zubovskiĭ GA; Smirnova GI; Leonova LN
    Pediatriia; 1978 Aug; (8):38-42. PubMed ID: 693181
    [No Abstract]   [Full Text] [Related]  

  • 6. [Insulin secretion and action in acromegaly].
    Borisova AM; Ovcharova N; Kirilov G
    Vutr Boles; 1987; 26(6):76-81. PubMed ID: 3326280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly.
    Rieu M; Girard F; Bricaire H; Binoux M
    J Clin Endocrinol Metab; 1982 Jul; 55(1):147-53. PubMed ID: 7042736
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcitonin, a diabetogenic hormone?
    Passariello N; Giugliano D; Sgambato S; Torella R; D'Onofrio F
    J Clin Endocrinol Metab; 1981 Aug; 53(2):318-23. PubMed ID: 7019230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in carbohydrate metabolism in hepatic cirrhosis].
    Conde Yagüe R; Gutiérrez-Cortines Corral MD; Ledesma Castaño F; González Coterillo T; Ortiz Ortiz M; Ramos Fernández R
    Rev Clin Esp; 1985 Sep; 177(4):160-4. PubMed ID: 3906788
    [No Abstract]   [Full Text] [Related]  

  • 10. The somatostatin analogue SMS 201-995 in acromegaly: prolonged, preferential suppression of growth hormone but not pancreatic hormones.
    George SR; Hegele RA; Burrow GN
    Clin Invest Med; 1987 Jul; 10(4):309-15. PubMed ID: 2888554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of carbohydrate metabolic disorders and of the secretion of insulin, glucagon and somatotropin in patients with chronic glomerulonephritis and chronic kidney failure].
    Trusov VV; Kazakova IA; Nasachev AA
    Ter Arkh; 1986; 58(8):13-8. PubMed ID: 3532406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepant effect of the prostaglandin synthesis inhibitor acetylsalicylic acid on insulin and C-peptide response to glucose in man.
    Ratzmann KP; Besch W; Witt S; Schulz B
    Horm Metab Res; 1982 Oct; 14(10):508-12. PubMed ID: 6757082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pancreatic hormone secretion in patients with newly detected diabetes mellitus].
    Belovalova IM; Kniazeva AP; Starosel'tseva LK; Perelygina AA
    Probl Endokrinol (Mosk); 1988; 34(6):3-6. PubMed ID: 3070538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of TRF, propranolol-glucagon, insulin and glucose stimulation tests in acromegaly.
    Coutant G; Vandeweghe M; Vermeulen A
    Horm Metab Res; 1977 Jan; 9(1):17-21. PubMed ID: 403115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of insulin, C-peptide and glucagon in liver cirrhosis.
    Gragnoli G; Signorini AM; Tanganelli I
    J Endocrinol Invest; 1981; 4(1):1-5. PubMed ID: 7016966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the glucagon and growth hormone levels in the blood plasma of healthy persons and of patients with disordered glucose tolerance after insulin administration].
    Tikhonova NE; Alekseeva GG
    Probl Endokrinol (Mosk); 1986; 32(1):22-5. PubMed ID: 3513155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nocturnal monitoring of growth hormone, insulin, C-peptide, and glucose in patients with acromegaly.
    Tsai JS; Zorrilla LL; Jacob KK; Rosenberg S; Marcus DL
    Am J Med Sci; 1996 Jun; 311(6):281-5. PubMed ID: 8659555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate metabolism and plasma levels of insulin and glucagon in patients with atherosclerotic vascular disease.
    Carreiro-Pousada JM; Garrote FJ; Rovira A; Herrera-Pombo JL; Valverde I
    Diabete Metab; 1988; 14(3):277-82. PubMed ID: 3044864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long term bromocriptine treatment on glucose intolerance in acromegaly.
    Chiba T; Chihara K; Minamitani N; Goto B; Kadowaki S; Taminato T; Matsukura S; Fujita T
    Horm Metab Res; 1982 Feb; 14(2):57-61. PubMed ID: 7040191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block.
    Gerö L; Korányi L; Szalay F; Büki B; Tamás G
    Acta Diabetol Lat; 1982; 19(1):55-64. PubMed ID: 7041501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.